The International Myeloma Foundation is dedicated to improving the lives of multiple myeloma patients while working toward
prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
The U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma (RRMM)
Join us for an unforgettable evening for an important cause. Laughter is the best medicine: It brings awareness and hope to the challenge of finding a cure for myeloma.
Enter to win a 10-day stay at the Villa Ono Oasis in historic Kailua-Kona, Hawaii. Only 1000 tix will be sold @ $50 each. Get more information now!
The International Myeloma Foundation funds research grants annually, including the Brian D. Novis Research Grants. Apply by August 1, 2019.
A recent study tantalized the myeloma community by showing that lenalidomide delayed the onset of active disease in patients with high-risk smoldering myeloma. But will scientists ever be able to prevent cancers such as myeloma?
In this week's video, Dr. Durie discusses how to tell if you are refractory to the drug Revlimid® and what other combination therapies could be available as an alternative.
Need to stay informed about the news that impacts myeloma patients, but don’t have time to read everything out there? Then be sure to follow Dr. Brian Durie’s Week in Review blog. The leading myeloma expert and IMF Chairman of the Board drills down on a wide range of topics – from the latest myeloma research results to the environmental issues that offer insight into prevention. He sifts through the data to deliver the bottom line.
The support of loved ones allows us to continue to fund efforts to search for a cure. Check out how Fundraisers are helping in the fight against myeloma.
